{{Rsnum
|rsid=1799852
|Gene=TF
|Chromosome=3
|position=133756878
|Orientation=plus
|ReferenceAllele=C
|GMAF=0.1405
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=TF
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 86.7 | 11.5 | 1.8
| HCB | 58.4 | 35.8 | 5.8
| JPT | 61.1 | 33.6 | 5.3
| YRI | 89.8 | 10.2 | 0.0
| ASW | 91.2 | 7.0 | 1.8
| CHB | 58.4 | 35.8 | 5.8
| CHD | 54.1 | 40.4 | 5.5
| GIH | 66.3 | 29.7 | 4.0
| LWK | 95.5 | 4.5 | 0.0
| MEX | 69.0 | 31.0 | 0.0
| MKK | 78.2 | 19.9 | 1.9
| TSI | 72.5 | 23.5 | 3.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19084217
|Trait=Serum markers of iron status
|Title=Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels
|RiskAllele=
|Pval=0.000005
|OR=0.43
|ORtxt=[0.25-0.61] SD decrease
|OA=1
}}

{{omim
|desc=TRANSFERRIN; TF
|id=190000
|rsnum=1799852
}}

{{PharmGKB
|RSID=rs1799852
|Name_s=
|Gene_s=TF
|Feature=Exon/Syn
|Evidence=PubMed ID:19084217
|Annotation=In a GWAS performed on 459 female monozygotic twin pairs, all Australians of European descent, this SNP was found to be significantly associated with serum transferrin (p = 4.7 x 10 (-6)).
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA164920574
}}

{{PharmGKB
|RSID=rs1799852
|Name_s=
|Gene_s=TF
|Feature=Exon/Syn
|Evidence=PubMed ID:19084217; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. (Initial Sample Size: 459 twin pairs; Replication Sample Size: NR); (Region: 3q22.1; Reported Gene(s): TF; Risk Allele: rs1799852-?); (p-value= 0.000005).This variant is associated with Serum markers of iron status.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740113
}}

{{PMID|16251468|OA=1
}} Survey of allelic expression using EST mining.

{{PMID|17601350|OA=1
}} A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition.

{{PMID|19673882|OA=1
}} A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis.

{{PMID|21978626|OA=1
}} potential markers of iron deficiency anaemia risk: two in the transferrin gene TF (rs3811647, rs1799852) and two in the HFE gene (C282Y, H63D), explain 35% of the genetic variation or heritability of serum transferrin in menstruating women. The minor allele of rs3811647 was associated with higher serum transferrin levels and lower transferrin saturation, while the minor alleles of rs1799852 and the C282Y and H63D mutations of HFE were associated with lower serum transferrin levels.

http://www.nutritionandmetabolism.com/content/8/1/69

{{PMID|19084217|OA=1
}} serum transferrin: Two SNPs on TF gene, rs1799852 (MAF 0.09), and rs2280673 (MAF 0.34), which were independently influencing variation in serum transferrin (nominal p = 4.7 × 10−6 and 2.3 × 10−4, respectively).  

rs1799852 and rs2280673 were also associated with serum ferritin (p = 0.04 and 0.003) but not with serum iron or transferrin saturation.  

These findings are potentially important for our understanding of iron metabolism and of regulation of hepatic protein secretion, and also strongly support the hypothesis that the genetic architecture of some endophenotypes may be simpler than that of disease.

{{PMID|21978626|OA=1
}} potential markers of iron deficiency anaemia risk: two in the transferrin gene TF (rs3811647, rs1799852) and two in the HFE gene (C282Y, H63D), explain 35% of the genetic variation or heritability of serum transferrin in menstruating women. The minor allele of rs3811647 was associated with higher serum transferrin levels and lower transferrin saturation, while the minor alleles of rs1799852 and the C282Y and H63D mutations of HFE were associated with lower serum transferrin levels.

http://www.nutritionandmetabolism.com/content/8/1/69

{{PMID|19084217|OA=1
}} serum transferrin: Two SNPs on TF gene, rs1799852 (MAF 0.09), and rs2280673 (MAF 0.34), which were independently influencing variation in serum transferrin (nominal p = 4.7 × 10−6 and 2.3 × 10−4, respectively).  

rs1799852 and rs2280673 were also associated with serum ferritin (p = 0.04 and 0.003) but not with serum iron or transferrin saturation.  

These findings are potentially important for our understanding of iron metabolism and of regulation of hepatic protein secretion, and also strongly support the hypothesis that the genetic architecture of some endophenotypes may be simpler than that of disease.

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1799852
|overall_frequency_n=917
|overall_frequency_d=10758
|overall_frequency=0.0852389
|n_genomes=5
|n_genomes_annotated=0
|n_haplomes=5
|n_articles=1
|n_articles_annotated=1
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}